Price Chart

Profile

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
URL https://www.smmttx.com
Investor Relations URL https://www.smmttx.com/investor-information/
HQ State/Province Florida
Sector Health Care
Industry Biotechnology
Equity Style Mid Cap/Growth
Next Earnings Release Feb. 20, 2025 (est.)
Last Earnings Release Oct. 30, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
URL https://www.smmttx.com
Investor Relations URL https://www.smmttx.com/investor-information/
HQ State/Province Florida
Sector Health Care
Industry Biotechnology
Equity Style Mid Cap/Growth
Next Earnings Release Feb. 20, 2025 (est.)
Last Earnings Release Oct. 30, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A